In a world obsessed with digital threats, BioFlyte is building the immune system for the physical world. With just 15 employees and $12.8M in funding, they are tasked with a chillingly critical mission: detecting biological agents at scale. This isn't just another defense contractor; it's a specialized sensor network poised to redefine national security.

"BioFlyte isn't just monitoring the air; they are quantifying the invisible risks that keep the Pentagon up at night."

The leadership team is lean but experienced. With Todd Sickles at the helm as President and CEO, supported by VPs of Engineering, Manufacturing, and Market Segments, the structure is optimized for rapid iteration on hardware and software. The $1.1M revenue on $12.8M funding suggests they are still in the R&D and early deployment stage, burning capital to perfect the tech before mass scaling.

• Ultra-Niche Focus: Exclusively targeting defense and biological threat detection, avoiding the crowded consumer health space.
• Lean Operations: Extremely high capital efficiency with only 15 employees managing multi-million dollar contracts.
• Direct Access Model: Heavy reliance on direct traffic (58%) indicates a proprietary, likely secure portal for government clients rather than a public-facing SaaS.